Assessment of general and acute toxicity of chitosan and diatomite-based feed additives In vivo
https://doi.org/10.52419/issn2072-2419.2025.4.214
Abstract
Chitosan and its derivatives are also used in pharmaceuticals as an excipient, a carrier of a drug or a therapeutic agent. The study was conducted on the basis of the Department of Biochemistry and Physiology of the St. Petersburg State University of Veterinary Medicine. A systematic review of the literature on toxicological studies of chitosan (in vitro and in vivo) was performed. The aim of this study was to test the safety of a feed additive containing chitosan using bioassay methods for general toxicity. An experimental sample of a feed additive was developed based on burnt diatomite (0.3-0.7 mm) and a concentrate of water-soluble chitosan. Toxicity during repeated administration in vivo. The general toxicity and acute toxicity of Danio rerio were determined in accordance with GOST 31674-2012 "Feed, compound feed, and feed raw materials. Methods for determining general toxicity." The infusoria were kept in a Lozin-Lozinsky medium prepared according to GOST 31674 -2012. The effect of the aqueous extract on the test system was evaluated in microaquaria using immunological plates. Survival control was performed using a light microscope at a magnification of 100x. Observations were made in both the control solution and the aqueous extract 30 minutes, 1 hour, 2 hours, and 3 hours after the start of the experiment. The biotesting was performed with double repetition for each sample. The survival rate of ciliates after 3 hours in an aqueous extract of the undiluted sample is 83%; the survival rate of ciliates after 3 hours in an aqueous extract of the diluted sample is 83%. The results of the studies showed that the presented sample of a feed additive containing chitosan and diatomite is non-toxic (harmless). The article also discusses possible mechanisms of the toxic effect of chitosan and recommendations for safe use in veterinary medicine.
About the Authors
A. B. BalykinaRussian Federation
PhD of Veterinary Sciences, Assoc. Prof.
L. Yu. Karpenko
Russian Federation
D.Biol.sc. Professor
M. V. Kiyanchuk
Russian Federation
assistant of the Department of Biochemistry and Physiology
I. N. Nikonov
Russian Federation
Cand.biol.sc.
References
1. Balykina A.B., Karpenko L.Yu., Kiyanchuk M.V., Nikonov I.N. Physiological and biochemical aspects of the application of Chitosan in veterinary medicine. International Bulletin of Veterinary Medicine. – 2025. – No. 3. – Pp. 385-277. (In Russ.)
2. Hematological characteristics in pregnant Saanen goats / P. Bokhan, A. Bakhta, L. Karpenko [et al.] // Reproduction in Domestic Animals. – 2019. – Vol. 54, No. S3. – Pp. 107-108. – EDN OXJEIU. (In Russ.)
3. Toxicological assessment of a biopreparation for composting / I. A. Makhnin, L. Yu. Karpenko, I. N. Nikonov [et al.] // Week of Science at IEIT: Proceedings of the AllRussian Conference, St. Petersburg, November 18–23, 2024. – St. Petersburg: Federal State Autonomous Educational Institution of Higher Education "Peter the Great St. Petersburg Polytechnic University", 2024. – Pp. 230-232. – EDN KUXDFG. (In Russ.)
4. The effect of the mycotoxin eliminator "Elitox" on the immune profile of the offspring in pregnant cows in the last trimester of pregnancy / A. Kozitsyna, L. Karpenko,. Bakhta [et al.] // Reproduction in Domestic Animals. – 2018. – Vol. 53, No. S2. – P. 153. – YKVLI Publishing House
5. Meramo-Hurtado S, Ceballos-Arrieta N, Cortez-Caballero J, Leon-Pulido J, Gonzalez -Quiroga A, Gonzalez-Delgado A. Assessment of the internal safety of industrial production of chitosan microbeads modified with TiO2 nanoparticles. Biomolecules. April 13, 2021;11(4):568. doi: 10.3390/biom11040568. PMID: 33924286; PMCID: PMC8068982.
6. Salsabila S., Khairinisa M., Watoni N., Sufiawati I., Mohd Fuad V., Khairul Ikram N.K., Muchtaridi M. Toxicity of chitosanbased nanoparticles in vivo: a systematic review. Biotechnology of Artificial Cells Nanomed. 2025 December;53(1):1-15. doi: 10.1080/21691401.2025.2462328. Published on February 9, 2025. PMID: 39924869.
7. Abd El-Hack Y, El-Saadoni MT, Shafi Y, Zabermawi NM, Arif M, Batihah J, Hafaga AF, Abd El-Hakim YM, Al-Sagir AA. Antimicrobial and antioxidant properties of chitosan and its derivatives and their applications: a review. Int J Biol Macromol. 2020 Dec 1;164:2726-2744. doi: 10.1016/j.ijbiomac.2020.08.153. Published on August 22, 2020. Published in: Int J Biol Macromol. 2025, March;293:139051. doi: 10.1016/j.ijbiomac.2024.139051. Identification number: 32841671
8. Abdollahimaid F., Purani M., Mahdavi H., Mirzadeh H., Yunespour S., Moravvei H. Efficacy and Safety of Chitosan-Based Biocompatible Dressings Compared to Nanosilver Dressings (ActicoatTM) in the Treatment of Refractory Diabetic Wounds: A Randomized Clinical Trial. Dermatol., 2022 Sep;35(9):e15682. doi: 10.1111/publicationdate:15682. Epub, 2022, July 25. Identification number: 35778935.
9. Lagarto A,Merino N,Valdes O,Dominguez J,Spencer E,de la Paz N,Aparicio G. Safety assessment of chitosan and chitosan acid salts from the fungus panurilus argus Int J Biol Macromol. 2015 Jan; 72:1343-50. doi: 10.1016/j.ijbiomac. 2014.10.030. Epub 2014 October 24. PMID:25450835.
10. Naveed M,Phil left,Sohail m,Hasnat m,Baig MMFA,Ihsan au,Shumzaid m,Kakar mu,Mehmood t District,Akabar Dr,Hussain Mi, Zhou QG. Chitosan oligosaccharide (COS): an overview. Int J Biol Macromol. 2019 May 15;129:827-843. doi: 10.1016/j.ijbiomac. 2019.01.192. Epub 2019 Jan 29. PMID:30708011.
11. Hu YL, Qi W, Han F, Shao JZ, Gao JQ. Toxicity evaluation of biodegradable chitosan nanoparticles using a zebrafish embryo model. Int J Nanomedicine. 2011;6:3351-9. doi: 10.2147/IJN.S25853. Epub 2011 Dec 14. PMID: 22267920; PMCID: PMC3260029.
12. Boamah PO, Onumah J, Aduguba WO, Santo KG. Application of depolymerized chitosan in crop production: A review. Int J Biol Macromol. 2023 Apr 30;235:123858. doi: 10.1016/j.ijbiomac.2023.123858. Epub 2023 Mar 4. PMID: 36871686.
13. Ait Hamdan Y, Ait Baba A, Azraida H, Kabdy H, Oudadesse H, Chait A, Rhazi M. In vivo evaluation by oral administration of chitosan combined with bioactive glass against cadmium-induced toxicity in rats. Int J Biol Macromol. 2024 Sep;276(Pt 1):133845. doi: 10.1016/j.ijbiomac.2024.133845. Epub 2024 Jul 14. PMID: 39004258.
14. Baldrick P. The safety of chitosan as an pharmaceutical excipient. Regular toxicol herbs. 2010 Apr; 56 (3):290-9. doi:10.1016/j.yrtph. 2009.09.015. Epub 2009 Sep 27. PMID:19788905.
15. Pramanik S., Sali V. Interplay in Drug Delivery: A Review of Chitosan-Based Nanocarrier System. Int. J. Biol. Macromol. 2021;169:103-121. doi: 10.1016/j.ijbiomac.2020.12.083.
Review
For citations:
Balykina A.B., Karpenko L.Yu., Kiyanchuk M.V., Nikonov I.N. Assessment of general and acute toxicity of chitosan and diatomite-based feed additives In vivo. International Journal of Veterinary Medicine. 2025;(4):214-221. (In Russ.) https://doi.org/10.52419/issn2072-2419.2025.4.214
JATS XML


















